Use of transgenic parasites and host reporters to dissect events that promote interleukin-12 production during toxoplasmosis

Infection and Immunity

Volumn 82, Issue 10, 2014, Pages 4056-4067

  Christian, David A ^a   Koshy, Anita A ^b   Reuter, Morgan A ^a   Betts, Michael R ^a   Boothroyd, John C ^c   Hunter, Christopher A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^c STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CRE RECOMBINASE; INTERLEUKIN 12P40;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INTERACTION; CELL INVASION; CELL POPULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; HOST PARASITE INTERACTION; IMMUNOCOMPETENT CELL; IN VIVO STUDY; MACROPHAGE; MONOCYTE; MOUSE; NONHUMAN; PHAGOCYTOSIS; PROTEIN EXPRESSION; TOXOPLASMA GONDII; TOXOPLASMOSIS; ANIMAL; GENETICS; IMMUNOLOGY; PARASITOLOGY; TOXOPLASMA;

ANIMALS; DENDRITIC CELLS; HOST-PARASITE INTERACTIONS; INTERLEUKIN-12 SUBUNIT P40; MACROPHAGES; MICE; MONOCYTES; TOXOPLASMA; TOXOPLASMOSIS;

EID: 84907100855     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01643-14     Document Type: Article

References (57)

1. Robert-Gangneux F, Darde ML. 2012. Epidemiology of and diagnostic strategies for toxoplasmosis. Clin. Microbiol. Rev. 25:264-296. http://dx.doi.org/10.1128/CMR.05013-11.
2. Gazzinelli RT, Hieny S, Wynn TA, Wolf S, Sher A. 1993. Interleukin 12 is required for the T-lymphocyte-independent induction of interferon gamma by an intracellular parasite and induces resistance in T-cell-deficient hosts. Proc. Natl. Acad. Sci. U. S. A. 90:6115-6119. http://dx.doi.org/10.1073/pnas.90.13.6115.
3. Gazzinelli RT, Wysocka M, Hayashi S, Denkers EY, Hieny S, Caspar P, Trinchieri G, Sher A. 1994. Parasite-induced IL-12 stimulates early IFNgamma synthesis and resistance during acute infection with Toxoplasma gondii. J. Immunol. 153:2533-2543.
4. Hunter CA, Candolfi E, Subauste C, Van Cleave V, Remington JS. 1995. Studies on the role of interleukin-12 in acute murine toxoplasmosis. Immunology 84:16-20.
5. Lieberman LA, Cardillo F, Owyang AM, Rennick DM, Cua DJ, Kastelein RA, Hunter CA. 2004. IL-23 provides a limited mechanism of resistance to acute toxoplasmosis in the absence of IL-12. J. Immunol. 173: 1887-1893. http://dx.doi.org/10.4049/jimmunol.173.3.1887.
6. Scharton-Kersten T, Contursi C, Masumi A, Sher A, Ozato K. 1997. Interferon consensus sequence binding protein-deficient mice display impaired resistance to intracellular infection due to a primary defect in interleukin 12 p40 induction. J. Exp. Med. 186:1523-1534. http://dx.doi.org/10.1084/jem.186.9.1523.
7. Scharton-Kersten TM, Wynn TA, Denkers EY, Bala S, Grunvald E, Hieny S, Gazzinelli RT, Sher A. 1996. In the absence of endogenous IFN-gamma, mice develop unimpaired IL-12 responses to Toxoplasma gondii while failing to control acute infection. J. Immunol. 157:4045- 4054.
8. Yap G, Pesin M, Sher A. 2000. Cutting edge: IL-12 is required for the maintenance of IFN-gamma production in T cells mediating chronic resistance to the intracellular pathogen, Toxoplasma gondii. J. Immunol. 165:628-631. http://dx.doi.org/10.4049/jimmunol.165.2.628.
9. Hunter CA, Sibley LD. 2012. Modulation of innate immunity by Toxoplasma gondii virulence effectors. Nat. Rev. Microbiol. 10:766-778. http://dx.doi.org/10.1038/nrmicro2858.
10. MacMicking JD. 2012. Interferon-inducible effector mechanisms in cellautonomous immunity. Nat. Rev. Immunol. 12:367-382. http://dx.doi.org/10.1038/nri3210.
11. Qiao Y, Giannopoulou EG, Chan CH, Park SH, Gong S, Chen J, Hu X, Elemento O, Ivashkiv LB. 2013. Synergistic activation of inflammatory cytokine genes by interferon-gamma-induced chromatin remodeling and Toll-like receptor signaling. Immunity 39:454-469. http://dx.doi.org/10.1016/j.immuni.2013.08.009.
12. Ma X, Chow JM, Gri G, Carra G, Gerosa F, Wolf SF, Dzialo R, Trinchieri G. 1996. The interleukin 12 p40 gene promoter is primed by interferon gamma in monocytic cells. J. Exp. Med. 183:147-157. http://dx.doi.org/10.1084/jem.183.1.147.
13. Yarovinsky F. 2014. Innate immunity to Toxoplasma gondii infection. Nat. Rev. Immunol. 14:109-121. http://dx.doi.org/10.1038/nri3598.
14. Mordue DG, Sibley LD. 2003. A novel population of Gr-1+-activated macrophages induced during acute toxoplasmosis. J. Leukoc. Biol. 74: 1015-1025. http://dx.doi.org/10.1189/jlb.0403164.
15. Bliss SK, Butcher BA, Denkers EY. 2000. Rapid recruitment of neutrophils containing prestored IL-12 during microbial infection. J. Immunol. 165:4515-4521. http://dx.doi.org/10.4049/jimmunol.165.8.4515.
16. Bliss SK, Zhang Y, Denkers EY. 1999. Murine neutrophil stimulation by Toxoplasma gondii antigen drives high level production of IFN-gammaindependent IL-12. J. Immunol. 163:2081-2088.
17. Robben PM, Mordue DG, Truscott SM, Takeda K, Akira S, Sibley LD. 2004. Production of IL-12 by macrophages infected with Toxoplasma gondii depends on the parasite genotype. J. Immunol. 172:3686-3694. http://dx.doi.org/10.4049/jimmunol.172.6.3686.
18. Goldszmid RS, Caspar P, Rivollier A, White S, Dzutsev A, Hieny S, Kelsall B, Trinchieri G, Sher A. 2012. NK cell-derived interferon-gamma orchestrates cellular dynamics and the differentiation of monocytes into dendritic cells at the site of infection. Immunity 36:1047-1059. http://dx.doi.org/10.1016/j.immuni.2012.03.026.
19. Hou B, Benson A, Kuzmich L, DeFranco AL, Yarovinsky F. 2011. Critical coordination of innate immune defense against Toxoplasma gondii by dendritic cells responding via their Toll-like receptors. Proc. Natl. Acad. Sci. U. S. A. 108:278-283. http://dx.doi.org/10.1073/pnas.1011549108.
20. Liu CH, Fan YT, Dias A, Esper L, Corn RA, Bafica A, Machado FS, Aliberti J. 2006. Cutting edge: dendritic cells are essential for in vivo IL-12 production and development of resistance against Toxoplasma gondii infection in mice. J. Immunol. 177:31-35. http://dx.doi.org/10.4049/jimmunol.177.1.31.
21. Mashayekhi M, Sandau MM, Dunay IR, Frickel EM, Khan A, Gold Szmid RS, Sher A, Ploegh HL, Murphy TL, Sibley LD, Murphy KM. 2011. CD8alpha(+) dendritic cells are the critical source of interleukin-12 that controls acute infection by Toxoplasma gondii tachyzoites. Immunity 35:249-259. http://dx.doi.org/10.1016/j.immuni.2011.08.008.
22. Reis e Sousa C, Hieny S, Scharton-Kersten T, Jankovic D, Charest H, Germain RN, Sher A. 1997. In vivo microbial stimulation induces rapid CD40 ligand-independent production of interleukin 12 by dendritic cells and their redistribution to T cell areas. J. Exp. Med. 186:1819-1829.
23. Pepper M, Dzierszinski F, Wilson E, Tait E, Fang Q, Yarovinsky F, Laufer TM, Roos D, Hunter CA. 2008. Plasmacytoid dendritic cells are activated by Toxoplasma gondii to present antigen and produce cytokines. J. Immunol. 180:6229-6236. http://dx.doi.org/10.4049/jimmunol.180.9.6229.
24. Koblansky AA, Jankovic D, Oh H, Hieny S, Sungnak W, Mathur R, Hayden MS, Akira S, Sher A, Ghosh S. 2013. Recognition of profilin by Toll-like receptor 12 is critical for host resistance to Toxoplasma gondii. Immunity 38:119-130. http://dx.doi.org/10.1016/j.immuni.2012.09.016.
25. Melo MB, Kasperkovitz P, Cerny A, Konen-Waisman S, Kurt-Jones EA, Lien E, Beutler B, Howard JC, Golenbock DT, Gazzinelli RT. 2010. UNC93B1 mediates host resistance to infection with Toxoplasma gondii. PLoS Pathog. 6:e1001071. http://dx.doi.org/10.1371/journal.ppat.1001071.
26. Scanga CA, Aliberti J, Jankovic D, Tilloy F, Bennouna S, Denkers EY, Medzhitov R, Sher A. 2002. Cutting edge: MyD88 is required for resistance to Toxoplasma gondii infection and regulates parasite-induced IL-12 production by dendritic cells. J. Immunol. 168:5997-6001. http://dx.doi.org/10.4049/jimmunol.168.12.5997.
27. Yarovinsky F, Zhang D, Andersen JF, Bannenberg GL, Serhan CN, Hayden MS, Hieny S, Sutterwala FS, Flavell RA, Ghosh S, Sher A. 2005. TLR11 activation of dendritic cells by a protozoan profilin-like protein. Science 308:1626-1629. http://dx.doi.org/10.1126/science.1109893.
28. Mordue DG, Hakansson S, Niesman I, Sibley LD. 1999. Toxoplasma gondii resides in a vacuole that avoids fusion with host cell endocytic and exocytic vesicular trafficking pathways. Exp. Parasitol. 92:87-99. http://dx.doi.org/10.1006/expr.1999.4412.
29. Mordue DG, Sibley LD. 1997. Intracellular fate of vacuoles containing Toxoplasma gondii is determined at the time of formation and depends on the mechanism of entry. J. Immunol. 159:4452-4459.
30. Braun L, Brenier-Pinchart MP, Yogavel M, Curt-Varesano A, Curt-Bertini RL, Hussain T, Kieffer-Jaquinod S, Coute Y, Pelloux H, Tardieux I, Sharma A, Belrhali H, Bougdour A, Hakimi MA. 2013. A Toxoplasma dense granule protein, GRA24, modulates the early immune response to infection by promoting a direct and sustained host p38MAPK activation. J. Exp. Med. 210:2071-2086. http://dx.doi.org/10.1084/jem.20130103.
31. Rosowski EE, Lu D, Julien L, Rodda L, Gaiser RA, Jensen KD, Saeij JP. 2011. Strain-specific activation of the NF-kappaB pathway by GRA15, a novel Toxoplasma gondii dense granule protein. J. Exp. Med. 208:195- 212. http://dx.doi.org/10.1084/jem.20100717.
32. Ewald SE, Chavarria-Smith J, Boothroyd JC. 2014. NLRP1 is an inflammasome sensor for Toxoplasma gondii. Infect. Immun. 82:460-468. http://dx.doi.org/10.1128/IAI.01170-13.
33. Sibley LD, Weidner E, Krahenbuhl JL. 1985. Phagosome acidification blocked by intracellular Toxoplasma gondii. Nature 315:416-419. http://dx.doi.org/10.1038/315416a0.
34. Pifer R, Benson A, Sturge CR, Yarovinsky F. 2011. UNC93B1 is essential for TLR11 activation and IL-12-dependent host resistance to Toxoplasma gondii. J. Biol. Chem. 286:3307-3314. http://dx.doi.org/10.1074/jbc.M110.171025.
35. Plattner F, Yarovinsky F, Romero S, Didry D, Carlier MF, Sher A, Soldati-Favre D. 2008. Toxoplasma profilin is essential for host cell invasion and TLR11-dependent induction of an interleukin-12 response. Cell Host Microbe 3:77-87. http://dx.doi.org/10.1016/j.chom.2008.01.001.
36. Whitmarsh RJ, Gray CM, Gregg B, Christian DA, May MJ, Murray PJ, Hunter CA. 2011. A critical role for SOCS3 in innate resistance to Toxoplasma gondii. Cell Host Microbe 10:224-236. http://dx.doi.org/10.1016/j.chom.2011.07.009.
37. Butcher BA, Fox BA, Rommereim LM, Kim SG, Maurer KJ, Yarovinsky F, Herbert DR, Bzik DJ, Denkers EY. 2011. Toxoplasma gondii rhoptry kinase ROP16 activates STAT3 and STAT6 resulting in cytokine inhibition and arginase-1-dependent growth control. PLoS Pathog. 7:e1002236. http://dx.doi.org/10.1371/journal.ppat.1002236.
38. Levings MK, Schrader JW. 1999. IL-4 inhibits the production of TNF alpha and IL-12 by STAT6-dependent and -independent mechanisms. J. Immunol. 162:5224-5229.
39. El Kasmi KC, Holst J, Coffre M, Mielke L, de Pauw A, Lhocine N, Smith AM, Rutschman R, Kaushal D, Shen Y, Suda T, Donnelly RP, Myers MG, Jr., Alexander W, Vignali DA, Watowich SS, Ernst M, Hilton DJ, Murray PJ. 2006. General nature of the STAT3-activated antiinflammatory response. J. Immunol. 177:7880-7888. http://dx.doi.org/10.4049/jimmunol.177.11.7880.
40. Madisen L, Zwingman TA, Sunkin SM, Oh SW, Zariwala HA, Gu H, Ng LL, Palmiter RD, Hawrylycz MJ, Jones AR, Lein ES, Zeng H. 2010. A robust and high-throughput Cre reporting and characterization system for the whole mouse brain. Nat. Neurosci. 13:133-140. http://dx.doi.org/10.1038/nn.2467.
41. Koshy AA, Dietrich HK, Christian DA, Melehani JH, Shastri AJ, Hunter CA, Boothroyd JC. 2012. Toxoplasma co-opts host cells it does not invade. PLoS Pathog. 8:e1002825. http://dx.doi.org/10.1371/journal.ppat.1002825.
42. Boothroyd JC, Dubremetz JF. 2008. Kiss and spit: the dual roles of Toxoplasma rhoptries. Nat. Rev. Microbiol. 6:79-88. http://dx.doi.org/10.1038/nrmicro1800.
43. John B, Harris TH, Tait ED, Wilson EH, Gregg B, Ng LG, Mrass P, Roos DS, Dzierszinski F, Weninger W, Hunter CA. 2009. Dynamic Imaging of CD8(_) T cells and dendritic cells during infection with Toxoplasma gondii. PLoS Pathog. 5:e1000505. http://dx.doi.org/10.1371/journal.ppat.1000505.
44. Koshy AA, Fouts AE, Lodoen MB, Alkan O, Blau HM, Boothroyd JC. 2010. Toxoplasma secreting Cre recombinase for analysis of host-parasite interactions. Nat. Methods 7:307-309. http://dx.doi.org/10.1038/nmeth.1438.
45. Ravindran S, Lodoen MB, Verhelst SH, Bogyo M, Boothroyd JC. 2009. 4-Bromophenacyl bromide specifically inhibits rhoptry secretion during Toxoplasma invasion. PLoS One 4:e8143. http://dx.doi.org/10.1371/journal.pone.0008143.
46. Wang L, Pietrek M, Brinkmann MM, Havemeier A, Fischer I, Hillenbrand B, Dittrich-Breiholz O, Kracht M, Chanas S, Blackbourn DJ, Schulz TF. 2009. Identification and functional characterization of a spliced rhesus rhadinovirus gene with homology to the K15 gene of Kaposi's sarcoma-associated herpesvirus. J. Gen. Virol. 90:1190-1201. http://dx.doi.org/10.1099/vir.0.007971-0.
47. Yamamoto M, Okuyama M, Ma JS, Kimura T, Kamiyama N, Saiga H, Ohshima J, Sasai M, Kayama H, Okamoto T, Huang DC, Soldati-Favre D, Horie K, Takeda J, Takeda K. 2012. A cluster of interferon-gammainducible p65 GTPases plays a critical role in host defense against Toxoplasma gondii. Immunity 37:302-313. http://dx.doi.org/10.1016/j.immuni.2012.06.009.
48. Reinhardt RL, Hong S, Kang SJ, Wang ZE, Locksley RM. 2006. Visualization of IL-12/23p40 in vivo reveals immunostimulatory dendritic cell migrants that promote Th1 differentiation. J. Immunol. 177:1618-1627. http://dx.doi.org/10.4049/jimmunol.177.3.1618.
49. Dupont CD, Christian DA, Selleck EM, Pepper M, Leney-Greene M, Harms Pritchard G, Koshy AA, Wagage S, Reuter MA, Sibley LD, Betts MR, Hunter CA. 2014. Parasite fate and involvement of infected cells in the induction of CD4_and CD8_T cell responses to Toxoplasma gondii. PLoS Pathog. 10:e1004047. http://dx.doi.org/10.1371/journal.ppat.1004047.
50. Striepen B, He CY, Matrajt M, Soldati D, Roos DS. 1998. Expression, selection, and organellar targeting of the green fluorescent protein in Toxoplasma gondii. Mol. Biochem. Parasitol. 92:325-338. http://dx.doi.org/10.1016/S0166-6851(98)00011-5.
51. Gubbels MJ, Li C, Striepen B. 2003. High-throughput growth assay for Toxoplasma gondii using yellow fluorescent protein. Antimicrob. Agents Chemother. 47:309-316. http://dx.doi.org/10.1128/AAC.47.1.309-316.2003.
52. Saeij JP, Boyle JP, Grigg ME, Arrizabalaga G, Boothroyd JC. 2005. Bioluminescence imaging of Toxoplasma gondii infection in living mice reveals dramatic differences between strains. Infect. Immun. 73:695-702. http://dx.doi.org/10.1128/IAI.73.2.695-702.2005.
53. Shaner NC, Campbell RE, Steinbach PA, Giepmans BN, Palmer AE, Tsien RY. 2004. Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent protein. Nat. Biotechnol. 22:1567-1572. http://dx.doi.org/10.1038/nbt1037.
54. Andrade WA, Souza Mdo C, Ramos-Martinez E, Nagpal K, Dutra MS, Melo MB, Bartholomeu DC, Ghosh S, Golenbock DT, Gazzinelli RT. 2013. Combined action of nucleic acid-sensing Toll-like receptors and TLR11/TLR12 heterodimers imparts resistance to Toxoplasma gondii in mice. Cell Host Microbe 13:42-53. http://dx.doi.org/10.1016/j.chom.2012.12.003.
55. Didierlaurent A, Goulding J, Patel S, Snelgrove R, Low L, Bebien M, Lawrence T, van Rijt LS, Lambrecht BN, Sirard JC, Hussell T. 2008. Sustained desensitization to bacterial Toll-like receptor ligands after resolution of respiratory influenza infection. J. Exp. Med. 205:323-329. http://dx.doi.org/10.1084/jem.20070891.
56. Chtanova T, Han SJ, Schaeffer M, van Dooren GG, Herzmark P, Striepen B, Robey EA. 2009. Dynamics of T cell, antigen-presenting cell, and pathogen interactions during recall responses in the lymph node. Immunity 31:342-355. http://dx.doi.org/10.1016/j.immuni.2009.06.023.
57. Gigley JP, Fox BA, Bzik DJ. 2009. Cell-mediated immunity to Toxoplasma gondii develops primarily by local Th1 host immune responses in the absence of parasite replication. J. Immunol. 182:1069-1078. http://dx.doi.org/10.4049/jimmunol.182.2.1069.